Navigation Links
Bacterin International to Present at Rodman & Renshaw Annual Global Investment Conference on September 12, 2011
Date:8/23/2011

BELGRADE, Mont., Aug. 23, 2011 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, has been invited to present at the Rodman & Renshaw Annual Global Investment Conference. The conference will be held at The Waldorf Astoria Hotel in New York City on September 11-13, 2011.

Bacterin's chairman and CEO, Guy Cook, and CFO, John Gandolfo, are scheduled to present on Monday, September 12, 2011 at 1:35 p.m. Eastern time, with one-on-one meetings held throughout the day. Management will discuss the company's business plan and objectives for the remainder of 2011.

The presentation will be available via webcast at www.wsw.com/webcast/rrshq20/bone. A replay link will also be available for 90 days following the live presentation on the company's website at www.bacterin.com.

Bacterin recently reported record revenue for the second quarter 2011 of $7.5 million, up 25% sequentially and 135% year-over-year. The company also reported its first positive EBITDA quarter of $33,000.

For more information about the conference or to schedule a one-on-one meeting with Bacterin management, contact your Rodman & Renshaw representative or the conference desk at 212-920-3595.

About Bacterin International Holdings

Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.

Bacterin's Medical Device division develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin's strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination. For further information, please visit www.bacterin.com.

Investor Relations:
Liolios Group, Inc.
Scott Liolios or Ron Both
Tel 949-574-3860
info@liolios.com


'/>"/>
SOURCE Bacterin International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bacterin Second Quarter 2011 Revenues up 135% Over Prior Year, Driving First Positive EBITDA Quarter
2. Bacterin Secures $15 Million Credit Facility with MidCap Financial and Silicon Valley Bank
3. Bacterin Sets Second Quarter 2011 Conference Call for Thursday, August 11, 2011 at 4:30 p.m. ET
4. Bacterin Joins Russell 3000, Russell Microcap, and Russell Global Indexes
5. Bacterin International Receives $1 million Initial Investment of $31 Million Purchase Agreement with Lincoln Park Capital Fund, LLC
6. Bacterin International Holdings, Inc. Reports First Quarter 2011 Financial Results
7. Bacterin International Holdings Launches Third Biologic Scaffold
8. Bacterin International Holdings, Inc. Schedules Conference Call to Present Fourth Quarter and Full Year 2010 Financial Results
9. Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex
10. Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge®SC
11. Bacterin International to Announce Launch of OsteoSponge®SC at American Academy of Orthopedic Surgeons 2011 Annual Meeting February 15-19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2019)... ... December 06, 2019 , ... ... implementation this month, Kenall is introducing the CSEDOIC luminaire series. CSEDOIC fixtures are ... now requires the unpacking of hazardous drugs (HDs) and HD-active pharmaceutical ingredients from ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... announce an expansion in services. While Kindred Nutrition and Wellness will continue ... they are now happy to offer Individual and Family Therapy and Yoga. , ...
(Date:12/6/2019)... ... December 06, 2019 , ... The Multiple System Atrophy Coalition ... bold new initiative to kickstart MSA research collaborations. Multiple system atrophy is ... by $3 million in new bequests earmarked for research and combined with ongoing ...
Breaking Medicine Technology:
(Date:12/8/2019)... ... , ... Intelligent.com, a trusted resource for online degree rankings ... 2020. The comprehensive research guide is based on an assessment of 104 accredited ... quality, graduation rate, reputation, and post-graduate employment. , The 2020 rankings are ...
(Date:12/6/2019)... Conn. (PRWEB) , ... December 06, 2019 , ... ... is consistently recognized for its innovations and excellence in patient care. On December ... that standard of excellence at the Health Care Heroes Awards at the Hartford ...
(Date:12/6/2019)... ... 06, 2019 , ... COMPLIANCY GROUP is proud to announce ... Society. Compliancy Group is dedicated to educating and assisting Wyoming Medical Society’s members ... the standards set forth by the Health Insurance Portability and Accountability Act (HIPAA). ...
(Date:12/5/2019)... ... December 05, 2019 , ... A cohort of plastic ... to help their patients more easily detect ruptured silicone gel implants. Dr. Herluf ... and reporting on his experience. While the FDA currently recommends regular MRI scans ...
(Date:12/5/2019)... ... 05, 2019 , ... It’s been an impactful year for ... people embrace, achieve, and maintain a healthy lifestyle to giving generously to communities ... mission of impacting world health, so it’s gratifying to look back on the ...
Breaking Medicine News(10 mins):